ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics during Extracorporeal Membrane Oxygenation: A multi-centre study to optimise drug therapy during ECMO

BMC Anesthesiology

Volumn 12, Issue , 2012, Pages

  Shekar, Kiran ^a   Roberts, Jason A ^b   Welch, Susan ^c   Buscher, Hergen ^c   Rudham, Sam ^c   Burrows, Fay ^c   Ghassabian, Sussan ^a   Wallis, Steven C ^b   Levkovich, Bianca ^d   Pellegrino, Vin ^d   McGuinness, Shay ^e   Parke, Rachael ^e   Gilder, Eileen ^e   Barnett, Adrian G ^f   Walsham, James ^g   Mullany, Daniel V ^a   Fung, Yoke L ^a   Smith, Maree T ^a   Fraser, John F ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d ALFRED HOSPITAL   (Australia)

^e AUCKLAND CITY HOSPITAL   (New Zealand)

^f QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^g PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Analgesics; Antibiotics; Drug toxicity; ECMO; Pharmacodynamics; Pharmacokinetics; Sedatives; Therapeutic failure

Indexed keywords

ALBUMIN; ANALGESIC AGENT; ANTIBIOTIC AGENT; BILIRUBIN; CASPOFUNGIN; CEFTRIAXONE; CIPROFLOXACIN; CREATININE; DEXMEDETOMIDINE; FENTANYL; FLUCONAZOLE; GENTAMICIN; LINEZOLID; MEROPENEM; MIDAZOLAM; MORPHINE; OSELTAMIVIR; PIPERACILLIN PLUS TAZOBACTAM; PROPOFOL; SEDATIVE AGENT; THIOPENTAL; TIMENTIN; VANCOMYCIN; VORICONAZOLE;

ADULT; ARTICLE; AUSTRALIA; BLOOD SAMPLING; CREATININE CLEARANCE; CRITICALLY ILL PATIENT; DISEASE SEVERITY; DRUG BLOOD LEVEL; EXTRACORPOREAL OXYGENATION; FEMALE; HEART FAILURE; HUMAN; INDWELLING CATHETER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEW ZEALAND; OPEN STUDY; PRESCRIPTION; RESPIRATORY FAILURE;

EID: 84870061354     PISSN: None     EISSN: 14712253     Source Type: Journal    
DOI: 10.1186/1471-2253-12-29     Document Type: Article

References (39)

1. Fraser JF, Shekar K, Diab S, Foley SR, McDonald CI, Passmore M, Simonova G, Roberts JA, Platts DG, Mullany DV, Fung YL. ECMO - the clinician's view. ISBT Science Series 2012, 7:82-88.
2. Beckmann A, Benk C, Beyersdorf F, Haimerl G, Merkle F, Mestres C, Pepper J, Wahba A. Position article for the use of extracorporeal life support in adult patients. Eur J Cardiothorac Surg 2011, 40(3):676-680.
3. MacLaren G, Combes A, Bartlett RH. Contemporary extracorporeal membrane oxygenation for adult respiratory failure: life support in the new era. Intensive Care Med 2012, 38(2):210-220. 10.1007/s00134-011-2439-2, 22147116.
4. ECLS Registry report Extracorporeal Life Support Organisation 2011, Ann Arbor( MI), ECLS Registry report.
5. Davies A, Jones D, Bailey M, Beca J, Bellomo R, Blackwell N, Forrest P, Gattas D, Granger E, Herkes R, et al. Extracorporeal membrane oxygenation for 2009 influenza a(H1N1) acute respiratory distress syndrome. JAMA 2009, 302(17):1888-1895.
6. Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, Hibbert CL, Truesdale A, Clemens F, Cooper N, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009, 374(9698):1351-1363. 10.1016/S0140-6736(09)61069-2, 19762075.
7. Lewandowski K. Extracorporeal membrane oxygenation for severe acute respiratory failure. Crit Care 2000, 4(3):156-168. 10.1186/cc689, 137254, 11094500.
8. Roberts DM, Roberts JA, Roberts MS, Liu X, Nair P, Cole L, Lipman J, Bellomo R. Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy - a multicentre pharmacokinetic study. Crit Care Med 2012, 40(5):1523-1528. 10.1097/CCM.0b013e318241e553, 22511133.
9. Udy AA, Varghese JM, Altukroni M, Briscoe S, McWhinney B, Ungerer J, Lipman J, Roberts JA. Sub-therapeutic initial beta-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations. Chest 2012, 142(1):30-39. 10.1378/chest.11-1671, 22194591.
10. Patel K, Roberts JA, Lipman J, Tett SE, Deldot ME, Kirkpatrick CM. Population pharmacokinetics of fluconazole in critically ill patients receiving continuous venovenous hemodiafiltration: using monte carlo simulations to predict doses for specified pharmacodynamic targets. Antimicrob Agents Chemother 2011, 55(12):5868-5873. 10.1128/AAC.00424-11, 3232768, 21930888.
11. Roberts JA, Taccone FS, Udy AA, Vincent JL, Jacobs F, Lipman J. Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens. Antimicrob Agents Chemother 2011, 55(6):2704-2709. 10.1128/AAC.01708-10, 3101407, 21402850.
12. Shekar K, Fraser JF, Smith MT, Roberts JA. Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation. J Crit Care 2012, Epub ahed of print.
13. Buck ML. Pharmacokinetic changes during extracorporeal membrane oxygenation: implications for drug therapy of neonates. Clin Pharmacokinet 2003, 42(5):403-417. 10.2165/00003088-200342050-00001, 12739981.
14. Alcorn J, McNamara PJ. Pharmacokinetics in the newborn. Adv Drug Deliv Rev 2003, 55(5):667-686. 10.1016/S0169-409X(03)00030-9, 12706549.
15. Shekar K, Roberts JA, Mullany DV, Corley A, Fisquet S, Bull TN, Barnett AG, Roberts JA, Fraser JF. Increased sedation requirements in patients receiving extracorporeal membrane oxygenation for respiratory and cardio-respiratory failure. Anaesth Intensive Care 2012, 40:648-655.
16. Shekar K, Roberts JA, Ghassabian S, Mullany DV, Ziegenfuss M, Smith MT, Fung YL, Fraser JF. Sedation during extracorporeal membrane oxygenation -why more is less?. Anaesth Intensive Care 2012, 40:6.
17. Mulla HGL, Firmin RK, David RU. Drug disposition during extracorporeal membrane oxygenation (ECMO). Paediatric and Perinatal Drug Therapy 2001, 4(3):109-120.
18. Shekar K, Roberts JA, Mcdonald CI, Fisquet S, Barnett AG, Mullany DV, Ghassabian S, Fung YL, Smith MT, Fraser JF. Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation. Crit Care 2012, 16(5):R194. Epub ahead of print, 10.1186/cc11679, 23068416.
19. Wildschut ED, Ahsman MJ, Allegaert K, Mathot RA, Tibboel D. Determinants of drug absorption in different ECMO circuits. Intensive Care Med 2010, 36(12):2109-2116. 10.1007/s00134-010-2041-z, 2981740, 20862453.
20. Bhatt-Mehta V, Johnson CE, Schumacher RE. Gentamicin pharmacokinetics in term neonates receiving extracorporeal membrane oxygenation. Pharmacotherapy 1992, 12(1):28-32.
21. Rosen DA, Rosen KR, Silvasi DL. In vitro variability in fentanyl absorption by different membrane oxygenators. J Cardiothorac Anesth 1990, 4(3):332-335. 10.1016/0888-6296(90)90041-D, 2131883.
22. Mulla H, Lawson G, von Anrep C, Burke MD, Upton DU, Firmin RK, Killer H. In vitro evaluation of sedative drug losses during extracorporeal membrane oxygenation. Perfusion 2000, 15(1):21-26.
23. Roberts JA, Roberts MS, Semark A, Udy AA, Kirkpatrick CM, Paterson DL, Roberts MJ, Kruger P, Lipman J. Antibiotic dosing in the 'at risk' critically ill patient: linking pathophysiology with pharmacokinetics/pharmacodynamics in sepsis and trauma patients. BMC Anesthesiol 2011, 11:3. 10.1186/1471-2253-11-3, 3050838, 21333028.
24. Roberts JA, Joynt GM, Choi GY, Gomersall CD, Lipman J. How to optimise antimicrobial prescriptions in the intensive care unit: principles of individualised dosing using pharmacokinetics and pharmacodynamics. Int J Antimicrob Agents 2012, 39(3):187-192. 10.1016/j.ijantimicag.2011.11.002, 22226651.
25. Roberts JA. Using PK/PD to optimize antibiotic dosing for critically Ill patients. Curr Pharm Biotechnol 2011, 12(12):2070-2079. 10.2174/138920111798808329, 21554211.
26. Sessler CN, Gosnell MS, Grap MJ, Brophy GM, O'Neal PV, Keane KA, Tesoro EP, Elswick RK. The richmond agitation-sedation scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med 2002, 166(10):1338-1344. 10.1164/rccm.2107138, 12421743.
27. Dasta JF, Kane SL, Gerlach AT, Cook CH. Bispectral index in the intensive care setting. Crit Care Med 2003, 31(3):998. author reply 998-999, 10.1097/01.CCM.0000055393.30990.1E, 12627033.
28. Ghassabian S, Moosavi SM, Valero YG, Shekar K, Fraser JF, Smith MT. High-throughput assay for simultaneous quantification of the plasma concentrations of morphine, fentanyl, midazolam and their major metabolites using automated SPE coupled to LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2012, 903:126-133.
29. Roberts JA, Kirkpatrick CM, Lipman J. Monte Carlo simulations: maximizing antibiotic pharmacokinetic data to optimize clinical practice for critically ill patients. J Antimicrob Chemother 2011, 66(2):227-231. 10.1093/jac/dkq449, 21118912.
30. Roberts JA, Field J, Visser A, Whitbread R, Tallot M, Lipman J, Kirkpatrick CM. Using population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury. Antimicrob Agents Chemother 2010, 54(9):3635-3640. 10.1128/AAC.00222-10, 2934958, 20547809.
31. Roberts JA, Kirkpatrick CM, Roberts MS, Robertson TA, Dalley AJ, Lipman J. Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte carlo dosing simulations and subcutaneous tissue distribution. J Antimicrob Chemother 2009, 64(1):142-150. 10.1093/jac/dkp139, 19398460.
32. Roberts JA, Kirkpatrick CM, Roberts MS, Dalley AJ, Lipman J. First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis. Int J Antimicrob Agents 2010, 35(2):156-163. 10.1016/j.ijantimicag.2009.10.008, 20018492.
33. Roberts JA. Relevance of pharmacokinetics to antibiotic dosing in critically ill patients. Curr Pharm Biotechnol 2011, 12(12):1981-1982. 10.2174/138920111798808310, 22432877.
34. Roberts JA, Lipman J. Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med 2009, 37(3):840-851. quiz 859, 10.1097/CCM.0b013e3181961bff, 19237886.
35. Shekar K, Roberts JA, Ghassabian S, Mullany DV, Wallis SC, Smith MT, Fraser JF. Altered antibiotic pharmacokinetics during extracorporeal membrane oxygenation: cause for concern?. J Antimicrob Chemother 2012, Oct 30. [Epub ahead of print].
36. Shekar K, Fung YL, Diab S, Mullany DV, McDonald CI, Dunster KR, Fisquet S, Platts DG, Stewart D, Wallis SC, et al. Development of simulated and ovine models of extracorporeal life support to improve understanding of circuit-host interactions. Crit Care Resusc 2012, 14(2):105-111.
37. Patel SB, Kress JP. Sedation and analgesia in the mechanically ventilated patient. Am J Respir Crit Care Med 2012, 185(5):486-497. 10.1164/rccm.201102-0273CI, 22016443.
38. Kollef MH. Optimizing antibiotic therapy in the intensive care unit setting. Crit Care 2001, 5(4):189-195. 10.1186/cc1022, 137278, 11511331.
39. Kollef MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 2000, 31(Suppl 4):S131.